On Invalid Date, Ocugen (NASDAQ: OCGN) reported Q4 2023 earnings per share (EPS) of -$0.04, up 66.67% year over year. Total Ocugen earnings for the quarter were -$9.49 million. In the same quarter last year, Ocugen's earnings per share (EPS) was -$0.12.
As of Q2 2024, Ocugen's earnings has grown year over year. Ocugen's earnings in the past year totalled -$63.08 million.
What is OCGN's earnings date?
Ocugen's earnings date is Invalid Date. Add OCGN to your watchlist to be reminded of OCGN's next earnings announcement.
What was OCGN's revenue last quarter?
On Invalid Date, Ocugen (NASDAQ: OCGN) reported Q4 2023 revenue of $6.04 million up 142.6% year over year. In the same quarter last year, Ocugen's revenue was $2.49 million.
What was OCGN's revenue growth in the past year?
As of Q2 2024, Ocugen's revenue has grown 142.6% year over year. This is 6.69 percentage points lower than the US Biotechnology industry revenue growth rate of 149.3%. Ocugen's revenue in the past year totalled $6.04 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.